The Board granted a disability rating of 100 percent from July 1, 2023, to July 31, 2023, for service-connected bladder cancer residuals and denied a compensable disability rating from August 1, 2023.
The deciding factor: The Veteran's treatment ceased on January 31, 2023, and there was no local reoccurrence or metastasis of the bladder cancer during the six-month period post-cessation of treatment. Therefore, a 100 percent rating is warranted for that period; however, routine surveillance cystoscopies are not considered treatment under DC 7528.
- Claimed conditions
- Bladder cancer residuals
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 100%
- Decision date
- October 24, 2025
- Citation
- A25092344
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.